Cargando…
High Expression of SLC16A1 as a Biomarker to Predict Poor Prognosis of Urological Cancers
OBJECTIVE: Tumor metabolism has always been the focus of cancer research. SLC16A1, as a key factor in catalysis of monocarboxylate transport across the plasma membrane, has been found to be associated with the occurrence and metastasis of a variety of cancers, but its prognostic significance and mec...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8493816/ https://www.ncbi.nlm.nih.gov/pubmed/34631536 http://dx.doi.org/10.3389/fonc.2021.706883 |